Healthcare, Regulatory and Reimbursement Landscape - Belgium

1
Healthcare, Regulatory and Reimbursement
Landscape - Belgium  

• Bharat Book Bureau

2
Summary

• Industry analysis specialist GlobalData has
  released its latest report Healthcare,
  Regulatory and Reimbursement Landscape -
  Belgium. An essential source of information and
  analysis on the Belgian healthcare, regulatory
  and reimbursement landscape, it identifies the
  key trends in the healthcare market and provides
  insights into the demographic, regulatory, and
  reimbursement landscape and healthcare
  infrastructure.
• Most importantly, the report provides valuable
  insights into the trends and segmentation of the
  pharmaceutical and medical device markets. It is
  built using data and information sourced from
  proprietary databases, secondary research and
  in-house analysis by team of industry experts.

3
Continue

• In 2012, Belgium had a population of 11 million.
  The pharmaceutical market was estimated to be
  worth 6.32 billion in 2013 at consumer-price
  level (including Value Added Tax (VAT) and
  excluding hospital sales) and is expected to
  reach 6.77 billion by 2020 at a projected
  Compound Annual Growth Rate (CAGR) of 0.98. The
  medical device market was worth approximately
  2.44 billion in 2013 and is expected to reach
  3.41 billion by 2020 at a CAGR of 4.9.
• These positive trends can primarily be attributed
  to - - RD investment- A conducive regulatory
  environment- Fast approval process and
  high-quality research, which attract companies
  wanting to conduct clinical trials- Increasing
  burden of elderly care- High per-capita
  healthcare expenditure

4
Continue

• These positive trends can primarily be attributed
  to - - RD investment- A conducive regulatory
  environment- Fast approval process and
  high-quality research, which attract companies
  wanting to conduct clinical trials- Increasing
  burden of elderly care- High per-capita
  healthcare expenditure
• Scope --
• The report provides information on the Belgian
  healthcare, regulatory and reimbursement
  landscape, including - Overview of the
  pharmaceutical and medical device markets,
  including size, segmentation, and key drivers and
  barriers

5
Continue

• Profiles and SWOT analyses of the major players
  in the pharmaceutical and medical device markets,
  namely Janssen Pharmaceutical, GlaxoSmithKline,
  Novartis, UCB, and Ablynx and Siemens
  Healthcare, Medtronic, F. Hoffmann-La Roche,
  Abbott Laboratories, and Essilor International-
  Insightful review of the reimbursement and
  regulatory landscape, with details of the
  reimbursement process, regulatory agencies and
  market authorization processes for new drug and
  medical devices- Detailed analysis of the
  Belgian political and economic environment,
  including economic indicators, demographics,
  healthcare infrastructure and healthcare
  expenditure- An overview of the opportunities
  for and challenges to growth in the Belgian
  healthcare marke

6
Continue

• Reasons to buy
• Develop business strategies by understanding the
  trends shaping and driving the healthcare
  marketDrive revenues by understanding the key
  trends, reimbursement and regulatory policies,
  pharmaceutical and medical devices market
  segments and companies likely to impact the
  healthcare market in the futureFormulate
  effective sales and marketing strategies by
  understanding the competitive landscape and
  analyzing the performance of various
  competitorsOrganize your sales and marketing
  efforts by identifying the market categories and
  segments that present the most opportunities for
  consolidation, investment and strategic
  partnershipsIdentify, understand and capitalize
  on the opportunities and challenges in the
  healthcare market

7
Table Of Contents

• 1 Table of Contents 51.1 List of Tables 71.2
  List of Figures 92 Introduction 112.1 Report
  Guidance 113 Overview of the Pharmaceutical and
  Medical Device Markets 123.1 Pharmaceutical
  Market 123.1.1 Market Overview 123.1.2
  Pharmaceutical Imports and Exports 153.1.3
  Supply Channels 163.1.4 Market Segments 173.1.5
  Major Therapeutic Areas 203.1.6 Major Players
  223.2 Medical Device Market 503.2.1 Market
  Overview 503.2.2 Overview of Top Five Segments
  523.2.3 Diagnostic Device Market 633.2.4 Major
  Players 65

8
Continue

• 3.3 Market Drivers and Barriers 843.3.1
  Drivers 843.3.2 Barriers 864 Market Access
  884.1 Reimbursement and Payer Landscape 884.1.1
  Overview of Healthcare System 884.1.2
  Reimbursement Process 974.1.3 Overview of
  Insurance Providers 1084.1.4 Patients Share in
  Healthcare Spending 1124.1.5 Healthcare Price
  Trends 1134.1.6 Pricing Policies 1144.2
  Regulatory Landscape 1154.2.1 Overview of
  Regulatory Agencies 1154.2.2 Market
  Authorization Procedure for Pharmaceutical
  Products 1204.2.3 New Medical Device Approval
  Process 1344.2.4 Licensing Process for
  Pharmaceutical and Medical Device Manufacturing
  139

9
For More Information You Can Visit-

• http//www.bharatbook.com/healthcare-market-
  research-reports/healthcare-regulatory-and-reimbur
  sement-landscape-belgium.html
• Or visit us at
• Bharat Book
  Bureau Phone
  91 22 27810772, 27810773
  Fax [phone]
  Toll Free No for USA/Canada
  1-866-279-8368
  E-mail info_at_bharatbook.com
  Website www.bharatbook.com
  Twitter
  https//twitter.com/BharatBook
  Blog http//blog.bharatbook.com/